Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Annkathrin Hanssen"'
Autor:
Svenja Schneegans, Jana Löptien, Angelika Mojzisch, Desirée Loreth, Oliver Kretz, Christoph Raschdorf, Annkathrin Hanssen, Antonia Gocke, Bente Siebels, Karthikeyan Gunasekaran, Yi Ding, Leticia Oliveira-Ferrer, Laura Brylka, Thorsten Schinke, Hartmut Schlüter, Ilkka Paatero, Hannah Voß, Stefan Werner, Klaus Pantel, Harriet Wikman
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-18 (2024)
Abstract Background Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal prognosis in NSCLC patients. He
Externí odkaz:
https://doaj.org/article/8ee82af4958b47ecbef81f24542bd06c
Autor:
Carlotta Riebensahm, Simon A. Joosse, Malte Mohme, Annkathrin Hanssen, Jakob Matschke, Yvonne Goy, Isabell Witzel, Katrin Lamszus, Jolanthe Kropidlowski, Cordula Petersen, Anja Kolb-Kokocinski, Sascha Sauer, Kerstin Borgmann, Markus Glatzel, Volkmar Müller, Manfred Westphal, Sabine Riethdorf, Klaus Pantel, Harriet Wikman
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-11 (2019)
Abstract Background The incidence of brain metastases in breast cancer (BCBM) patients is increasing. These patients have a very poor prognosis, and therefore, identification of blood-based biomarkers, such as circulating tumor cells (CTCs), and unde
Externí odkaz:
https://doaj.org/article/9ce323027a994649b8033de0443befc4
Autor:
Annkathrin Hanssen, Carlotta Riebensahm, Malte Mohme, Simon A. Joosse, Janna-Lisa Velthaus, Lars Arne Berger, Christian Bernreuther, Markus Glatzel, Sonja Loges, Katrin Lamszus, Manfred Westphal, Sabine Riethdorf, Klaus Pantel, Harriet Wikman
Publikováno v:
Cancers, Vol 10, Iss 12, p 527 (2018)
Forty percent of non-small cell lung cancer (NSCLC) patients develop brain metastases, resulting in a dismal prognosis. However, patients in an oligo-metastatic brain disease setting seem to have better outcomes. Here, we investigate the possibility
Externí odkaz:
https://doaj.org/article/d99d2f24d1714b6faeb1d79e427d8ccb
Autor:
Faik G Uzunoglu, Ebba Dethlefsen, Annkathrin Hanssen, Michaela Wrage, Lena Deutsch, Katharina Harms-Effenberger, Yogesh K Vashist, Matthias Reeh, Guido Sauter, Ronald Simon, Maximillian Bockhorn, Klaus Pantel, Jakob R Izbicki, Harriet Wikman
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113315 (2014)
This study was performed to assess the prognostic relevance of genomic aberrations at chromosome 4q in NSCLC patients. We have previously identified copy number changes at 4q12-q32 to be significantly associated with the early hematogenous disseminat
Externí odkaz:
https://doaj.org/article/6312138208bc422a8969085d34b4a2f8
Autor:
Maximilian Bockhorn, Klaus Pantel, Jacob R. Izbicki, Florian Gebauer, Michael Tachezy, Christine Eulenburg, Stefan Wolter, Annkathrin Hanssen, Cornelia Schroeder, Katharina E. Effenberger
Purpose: Pancreatic cancer is one of the most devastating diseases with a 5-year survival rate of 3% to 5%. Here, we investigated whether circulating tumor cells (CTC) may predict metastatic spread and survival in pancreatic cancer patients.Experimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c740af47ae543130b221d8591652948
https://doi.org/10.1158/1078-0432.c.6527651
https://doi.org/10.1158/1078-0432.c.6527651
Autor:
Maximilian Bockhorn, Klaus Pantel, Jacob R. Izbicki, Florian Gebauer, Michael Tachezy, Christine Eulenburg, Stefan Wolter, Annkathrin Hanssen, Cornelia Schroeder, Katharina E. Effenberger
Supplements Table 1. Multivariate analyses of progression-free survival and overall survival (n=57) of chemo-receiving patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d09b01f58e94e4827422282b3f285038
https://doi.org/10.1158/1078-0432.22470674
https://doi.org/10.1158/1078-0432.22470674
Autor:
Cordula Petersen, Yvonne Goy, Annkathrin Hanssen, Jakob Matschke, Isabell Witzel, Harriet Wikman, Katrin Lamszus, Volkmar Müller, Sabine Riethdorf, Jolanthe Kropidlowski, Kerstin Borgmann, Anja Kolb-Kokocinski, Carlotta Riebensahm, Sascha Sauer, Malte Mohme, Klaus Pantel, Manfred Westphal, Markus Glatzel, Simon A. Joosse
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 21, Iss 1, Pp 1-11 (2019)
Breast Cancer Research, Vol 21, Iss 1, Pp 1-11 (2019)
Background The incidence of brain metastases in breast cancer (BCBM) patients is increasing. These patients have a very poor prognosis, and therefore, identification of blood-based biomarkers, such as circulating tumor cells (CTCs), and understanding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cca9d394ed6085259f95cd44f5426c1
http://edoc.mdc-berlin.de/18419/2/18419suppl.zip
http://edoc.mdc-berlin.de/18419/2/18419suppl.zip
Autor:
Klaus Pantel, Harriet Wikman, Yvonne Goy, Annkathrin Hanssen, Malte Mohme, Katrin Lamszus, Cordula Petersen, Sonja Loges, Heather Scharpenseel, Sven Peine, Manfred Westphal, Markus Glatzel, Christian Bernreuther, Sabine Riethdorf
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Although clinically relevant, the detection rates of EpCAM positive CTCs in non-small cell lung cancer (NSCLC) are surprisingly low. To find new clinically informative markers for CTC detection in NSCLC, the expression of EGFR and HER3 was first anal
Autor:
Peter Iglauer, Sabine Riethdorf, Genny Buson, Markus Tiemann, Lars-Arne Berger, Kelli Bramlett, Ru Cao, Claudio Forcato, Ronald Simon, Martin Reck, Nicolò Manaresi, Isabel Ben-Batalla, Markus Falk, Melanie Janning, Carsten Bokemeyer, Guido Sauter, S. Schatz, Harriet Wikman, Janna-Lisa Velthaus, Annkathrin Hanssen, Sonja Loges, Klaus Pantel
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 13(12)
Autor:
Annkathrin Hanssen, Katharina E. Effenberger, J. R. Izbicki, Florian Gebauer, Cornelia Schroeder, Stefan Wolter, Maximilian Bockhorn, Klaus Pantel, Michael Tachezy, Christine Eulenburg
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 24(12)
Purpose: Pancreatic cancer is one of the most devastating diseases with a 5-year survival rate of 3% to 5%. Here, we investigated whether circulating tumor cells (CTC) may predict metastatic spread and survival in pancreatic cancer patients. Experime